Motion Sickness Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Motion Sickness Treatment Market is segmented By Treatment Type (Anticholinergics, Antihistamines, and others), Distribution Channel, and Geography

Market Snapshot

Motion Sickness Treatment Market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: >3.0 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The motion sickness treatment market is anticipated to witness a CAGR of nearly 3.0% during the forecast period. There are certain factors that are driving the market growth, including a rise in the number of travelers across the globe and increased incidences of cardiovascular diseases in the geriatric population which majorly cause motion sickness.

For instance, according to United Nations World Tourism Organization (UNWTO), international tourist arrivals increased by 5.4% in 2018 compared to 2017, and this tendency is expected to continue throughout the forecast period which demands higher requirements for motion sickness treatment globally. Also, ongoing research activities in motion sickness drug development and delivery systems are likely to increase the availability of OTC drugs for motion sickness treatment.

Scope of the Report

As per the scope of the report, motion sickness is a common disorder characterized by a set of symptoms such as dizziness, nausea, and fatigue experienced by a person while traveling due to differences in impulses in the eyes, other body tissues, and sensory receptors. Motion sickness is most commonly observed among children and geriatrics. It is experienced by about 50% to 70% of travelers and even while playing virtual reality (VR) games.

By Treatment Type
By Distribution Channel
Retail Pharmacies
Online Pharmacies
North America
United States
United Kingdom
Rest of Europe
South Korea
Rest of Asia-Pacific
Middle-East and Africa
South Africa
Rest of Middle-East and Africa
South America
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Anticholinergic Treatment Segment is Expected to Hold the Largest Market Share During the Forecast Period

The anticholinergic treatment segment is expected to account for a significant share of the motion sickness treatment market. The dominance in the revenue share of this segment is due to long-lasting relief, better efficacy, better patient-compliance, and fewer side effects compared to other treatments. Also, the growing demand along with the higher prices of these products is expected to contribute to the highest revenue of the segment during the forecast period.

Next to anticholinergics, the antihistamine treatment segment contributes to the second-highest revenue in the global market. This is due to their access to the patients in a wide range of dosage forms like transdermal patches, oral dosage forms such as chewable tablets, lozenges, etc., as per patient requirement. They are also available as prescriptions and various OTC drugs which are expected to account for their significant growth rate in the motion sickness treatment market.

By the distribution channel, the retail pharmacies segment is expected to have a high revenue share in the market and is expected to continue during the forecast period. The dominance is owing to the higher preference of self-medication and the access to patients which accounts for the significant share in the market.

Inflation Devices Market Share

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to account for the largest share of the motion sickness treatment. This is due to increased tourism in the U.S. and preference for highly expensive prescription drugs directly contributes to a significant share of revenue in the region. For instance, according to the UNWTO, in 2018, nearly 52 million International tourists travel from America to Europe resultant in a higher demand for the motion sickness treatment market in the region.

Followed by North America, Europe contributed to the second largest market share owing to a rise in a number of travelers all over the world, increased research activities and investors to develop novel drug delivery systems for motion sickness treatment accounts for the highest revenue.

Inflation Devices Market

Competitive Landscape

The motion sickness treatment market is moderately competitive and consists of several major players. Few of the major players currently dominating the market are implementing various development strategies such as making mergers and acquisitions, entering into partnerships and thus, expanding their footprint globally. 

Table of Contents


    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study




    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increased Number of Travellers and Virtual Reality Exposure Across the Globe

      2. 4.2.2 Rise in Adoption of Prescription Motion Sickness Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Reluctance in Emerging Countries due to Higher Cost of Prescription Drugs

      2. 4.3.2 Excessive Reliance on the OTC and Traditional Medicines

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry


    1. 5.1 By Treatment Type

      1. 5.1.1 Anticholinergics

      2. 5.1.2 Antihistamines

      3. 5.1.3 Others

    2. 5.2 By Distribution Channel

      1. 5.2.1 Retail Pharmacies

      2. 5.2.2 Online Pharmacies

      3. 5.2.3 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. United States

        2. Canada

        3. Mexico

      2. 5.3.2 Europe

        1. Germany

        2. United Kingdom

        3. France

        4. Italy

        5. Spain

        6. Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. China

        2. Japan

        3. India

        4. Australia

        5. South Korea

        6. Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. GCC

        2. South Africa

        3. Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. Brazil

        2. Argentina

        3. Rest of South America


    1. 6.1 Company Profiles

      1. 6.1.1 GlaxoSmithKline plc

      2. 6.1.2 Perrigo Company plc

      3. 6.1.3 Prestige Consumer Healthcare Inc.

      4. 6.1.4 WellSpring Pharmaceutical Corporation

      5. 6.1.5 Caleb Pharmaceuticals Inc

      6. 6.1.6 Myungmoon Pharm Co. Ltd

      7. 6.1.7 Baxter International Inc

      8. 6.1.8 CVS Health

    2. *List Not Exhaustive

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Motion Sickness Treatment Market market is studied from 2018 - 2026.

The Motion Sickness Treatment Market is growing at a CAGR of >3.0% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Prestige Consumer Healthcare Inc, WellSpring Pharmaceutical Corporation, Caleb Pharmaceuticals Inc, Myungmoon Pharm Co Ltd, CVS Health are the major companies operating in Motion Sickness Treatment Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!